Learn / KYMR
NASDAQ: KYMR
Kymera Therapeutics (KYMR) stock, explained like you're 5
Kymera Therapeutics trades on the Nasdaq under the ticker KYMR. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 9.3 billion dollars.
- Ticker
- KYMR
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 9.3 billion dollars
Is Kymera Therapeutics a small, medium or large cap company?
No. Kymera Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 9.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Kymera Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves KYMR stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- KYMR Stock Clocks Best Day In Over 6 Months On Advancing Eczema Trial Timeline (Stocktwits)
- KYMR Dec 2026 160.000 call (KYMR261218C00160000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Raymond James initiates Kymera Therapeutics stock coverage with outperform rating (Investing.com)
- Kymera Therapeutics (NASDAQ:KYMR) Stock Falls 5% Should You Sell? (MarketBeat)
- Why Kymera Therapeutics Stock Popped This Week (The Motley Fool)
Follow KYMR in your daily brief
Each trading day at 5 PM ET we post what happened to Kymera Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow KYMR
Questions about Kymera Therapeutics stock
What does Kymera Therapeutics do?
Kymera Therapeutics trades on the Nasdaq under the ticker KYMR. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 9.3 billion dollars.
What is the ticker symbol for Kymera Therapeutics?
Kymera Therapeutics trades under the ticker KYMR on the Nasdaq.
What is Kymera Therapeutics's market cap?
Kymera Therapeutics is a mid cap stock with a market cap of about 9.3 billion dollars.
How does Kymera Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves KYMR stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow KYMR stock every day?
Add KYMR to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.